We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$169M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$116M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$87.5M
4
ABBV icon
AbbVie
ABBV
+$80.5M
5
JPM icon
JPMorgan Chase
JPM
+$79.3M

Top Sells

Rank Stock Value
1
IGM icon
iShares Expanded Tech Sector ETF
IGM
+$79.2M
2
CMCSA icon
Comcast
CMCSA
+$69.1M
3
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$53.3M
4
META icon
Meta Platforms (Facebook)
META
+$48.1M
5
VZ icon
Verizon
VZ
+$41.8M

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITRI icon
3751
CALL
Itron
ITRI
$4.52B
$26.9K ﹤0.01%
+17,900
New +$884K
OPFI icon
3752
OppFi
OPFI
$562M
$26K ﹤0.01%
12,707
-4,000
-24% -$9.01K
DOW icon
3753
CALL
Dow Inc
DOW
$22.6B
$26K ﹤0.01%
85,700
+31,900
+59% +$1.56M
UGP icon
3754
Ultrapar
UGP
$6.34B
$25.8K ﹤0.01%
10,661
-3,845
-27% -$9.62K
AVT icon
3755
CALL
Avnet
AVT
$7.87B
$25K ﹤0.01%
12,500
– –
MRKR icon
3756
Marker Therapeutics
MRKR
$18.7M
$25K ﹤0.01%
9,400
– –
ME
3757
DELISTED
23andMe Holding Co
ME
$24.8K ﹤0.01%
573
-451
-44% -$26.3K
INO icon
3758
Inovio Pharmaceuticals
INO
$79.1M
$23.9K ﹤0.01%
1,275
-321
-20% -$7.28K
FUBO icon
3759
FuboTV Inc
FUBO
$293M
$23.8K ﹤0.01%
1,139
-24
-2% -$879
LCTX icon
3760
Lineage Cell Therapeutics
LCTX
$283M
$23.6K ﹤0.01%
20,173
-942
-4% -$1.19K
MCLD
3761
DELISTED
mCloud Technologies Corp. Common Shares
MCLD
$22.7K ﹤0.01%
25,677
-4,253
-14% -$4.49K
SCYX icon
3762
SCYNEXIS
SCYX
$48.1M
$22.5K ﹤0.01%
1,802
-43
-2% -$760
KO icon
3763
CALL
Coca-Cola
KO
$372B
$22.2K ﹤0.01%
17,200
+4,900
+40% +$296K
EGIO
3764
DELISTED
Edgio, Inc. Common Stock
EGIO
$22K ﹤0.01%
487
-407
-46% -$31.4K
SFT
3765
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$21.5K ﹤0.01%
+14,421
New +$54.8K
PICK icon
3766
CALL
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.33B
$21.4K ﹤0.01%
71,500
-200
-0.3% -$7.82K
EGLX
3767
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$21.4K ﹤0.01%
38,481
– –
DHY
3768
Credit Suisse High Yield Credit Fund
DHY
$242M
$21.1K ﹤0.01%
12,000
– –
BMY icon
3769
CALL
Bristol-Myers Squibb
BMY
$130B
$20.9K ﹤0.01%
+20,300
New +$1.53M
APTO
3770
DELISTED
Aptose Biosciences, Inc.
APTO
$20.6K ﹤0.01%
79
+51
+182% +$13.7K
QTTB icon
3771
Q32 Bio
QTTB
$459M
$20.1K ﹤0.01%
884
-53
-6% -$1.41K
PDYN icon
3772
Palladyne AI
PDYN
$312M
$19.6K ﹤0.01%
5,833
+3,583
+159% +$30.6K
GOEV
3773
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$19.5K ﹤0.01%
+35
New +$21.5K
APD icon
3774
CALL
Air Products & Chemicals
APD
$68.9B
$18.8K ﹤0.01%
26,800
+15,700
+141% +$4.42M
T icon
3775
CALL
AT&T
T
$168B
$18.7K ﹤0.01%
71,200
+33,200
+87% +$594K
149 150
151
152 153

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.